Articles by Disease (Non-melanoma Skin Cancer)

The HOX Gene Network as a Potential Target for Cancer Therapy

Journal: Current Cancer Therapy Reviews
Volume: 3
Page: 17-24
Author(s): Monica Cantile, Giulia Schiavo, Luigi Terracciano and Clemente Cillo

Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer

Journal: Current Cancer Drug Targets
Volume: 7
Page: 31-40
Author(s): Alexander J. Muller and George C. Prendergast

Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance

Journal: Current Cancer Drug Targets
Volume: 7
Page: 41-53
Author(s): Pedro Horna and Eduardo M. Sotomayor

T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity

Journal: Current Cancer Drug Targets
Volume: 7
Page: 55-70
Author(s): Jeurgen Foell and Becker Hewes

Small Molecule Inhibitors of Stat3 Signaling Pathway

Journal: Current Cancer Drug Targets
Volume: 7
Page: 91-107
Author(s): Jinxia Deng, Fedora Grande and Nouri Neamati

Subject Index To Volume 6

Journal: Current Molecular Medicine
Volume: 7
Page: v-xv
Author(s):

Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets

Journal: Current Pharmaceutical Design
Volume: 13
Page: 387-403
Author(s): Olga Vasiljeva, Thomas Reinheckel, Christoph Peters, Dusan Turk, Vito Turk and Boris Turk

NF-κB Signaling and Carcinogenesis

Journal: Current Pharmaceutical Design
Volume: 13
Page: 447-462
Author(s): Takashi Okamoto, Takaomi Sanda and Kaori Asamitsu

Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer

Journal: Current Pharmaceutical Design
Volume: 13
Page: 537-551
Author(s): Simone Mocellin, Pierluigi Pilati and Donato Nitti

In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells

Journal: Current Immunology Reviews (Discontinued)
Volume: 3
Page: 57-75
Author(s): Ross N. La Motte-Mohs, Geneve Awong and Juan Carlos Zuniga-Pflucker